The CyberKnife®, a stereotactic radiation therapy that accurately locates and targets tumors of the brain, neck and spine, is now available at Sinai Hospital. Patients diagnosed with inoperable tumors are learning that this groundbreaking and unique radiation therapy is also a viable option in their course of treatment.

The CyberKnife® is a computer-guided linear accelerator that can target a tumor with pinpoint accuracy and bombard it with huge doses of radiation. Patients benefit from the many advantages of CyberKnife® treatment, because it offers:

• painless and accurate treatment of tumors and lesions of the brain, head, neck and spine
• an alternative to surgery for many patients
• a noninvasive procedure that reduces or eliminates damage to surrounding tissue
• And patients can return home after treatment toresume normalactivities

  Sinai Hospital is the only Maryland hospital offering the CyberKnife®, a recent addition to the Alvin & Lois Lapidus Cancer Institute’s sophisticated array of services for cancer patients.

  The staff of the Sinai Hospital CyberKnife® Center stands ready to treat patients from Maryland, Pennsylvania, Delaware, Virginia, West Virginia and Washington, D.C. The team of professionals is led by:

  Alan Levine, M.D., Director of the Alvin & Lois Lapidus Cancer Institute

  Mark Brenner, M.D., Medical Director of the CyberKnife® Center

  Neal Naff, M.D., Surgical Director of the CyberKnife® Center

  Cardella Coleman, M.D., Associate Chief, Radiation Oncology

  For more information about the CyberKnife® and its benefits, call 410-601-WELL (9355).

  Related Links:

  CyberKnife® Center

  Sinai Hospital

  Alvin & Lois Lapidus Cancer Institute

  Radiation Oncology